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Background: Although procoagulant biomarkers are elevated in the setting of chronic kidney disease (CKD), the impact of CKD on thrombosis 
remains unknown.
Methods: We compared the kinetic properties of thrombus between non-dialysis dependent CKD patients (n=60) and unmatched healthy controls 
(n=41). Blood coagulability was meaured using thromboelastography (TEG), a whole-blood assay that measures clot formation time (cft), maximum 
clot firmness (mcf) and acceleration of fibrin cross-linking (alpha angle). Estimated glomerular filtration rate (eGFR) was calculated using the 
chronic kidney disease epidemiology collaboration (CKD-EPI) equation and patients were categorized by severity of renal dysfunction.
Results: CKD patients (mean eGFR 30.2 ± 1.8 ml/min/1.73m2) were significantly older (58.4 vs. 38.9 years, p<0.001) with a higher frequency of 
diabetes mellitus (26% vs. 2%, p=0.003) compared to their non-CKD counterparts. Clots formed more rapidly with greater tensile strength as renal 
function worsened (Table). Results remained consistent after excluding those with DM. While adjustment for baseline differences attenuated the 
findings for clot formation time and alpha angle, the association between CKD and mcf remained significant.
Conclusions: CKD is associated with a graded and strong impact on whole blood coagulation, resulting in clots that form more rapidly and exhibit 
a more stable phenotype. 
Table Hemostatic parameters by severity of renal dysfunction in entire study population and in non-diabetics
Entire population (n=99)
Estimated glomerular filtration rate (ml/min/1.73m2)
eGFR < 30 eGFR 30-59 eGFR ≥ 60 p-value
Clot Formation time (sec) 62.1 ± 19.8 70.2 ± 20.1 78.2 ± 17.5 0.002
Alpha angle 77.7 ± 3.7 76.3 ± 3.5 74.7 ± 3.2 0.001
Clot strength (mm) 67.8 ± 6.0 64.1 ± 5.5 61.6 ± 4.6 <0.001
Non-diabetics (n=83)
Estimated glomerular filtration rate (ml/min/1.73m2)
eGFR < 30 eGFR 30-59 eGFR ≥ 60 p-value
Clot Formation time (sec) 63.9 ± 20.3 74.2 ± 21.2 79.2 ± 17.2 0.01
Alpha angle 77.2 ± 3.7 75.7 ± 3.5 74.5 ± 3.2 0.01
Clot strength (mm) 67.3 ± 6.2 63.1 ± 4.7 61.3 ± 4.3 <0.001
*eGFR - estimated glomerular filtration rate;
